Ypsomed
Innovative, high-quality and reliable products and services which allow patients to administer their own medication in a safe and simple way.
Launch date
Employees
Market cap
€4.8b
Enterprise valuation
€5.0b (Public information from Sep 2024)
Share price
CHF427.5 YPSN.SW
Company register number CH-053.3.015.595-6
Bern Bern (HQ)
Authorizing premium user...